172 related articles for article (PubMed ID: 22269836)
1. [Advances in arterial hypertension and diabetes mellitus].
Cordero A; Lekuona I; Galve E; Mazón P;
Rev Esp Cardiol (Engl Ed); 2012 Jan; 65 Suppl 1():12-23. PubMed ID: 22269836
[TBL] [Abstract][Full Text] [Related]
2. [What do large clinical trials learn us about cardiovascular and renal prevention in patients with type 2 diabetes mellitus and hypertension?].
Dussol B; Berland Y
Nephrol Ther; 2006 May; 2(2):51-74. PubMed ID: 16895717
[TBL] [Abstract][Full Text] [Related]
3. [Cardiovascular disease in kidney transplantation].
Marcén R; Pascual J
Nefrologia; 2001; 21(2):104-14. PubMed ID: 11464644
[No Abstract] [Full Text] [Related]
4. [Progress in hypertension and diabetes in 2010].
Cordero A; Fácila L; Alonso A; Mazón P
Rev Esp Cardiol; 2011; 64 Suppl 1():20-9. PubMed ID: 21276487
[TBL] [Abstract][Full Text] [Related]
5. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
6. [Diabetes, hypertension and microalbuminuria in primary care].
Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
Fortschr Med Orig; 2003 Feb; 121 Suppl 1():33-8. PubMed ID: 14732948
[TBL] [Abstract][Full Text] [Related]
7. [Glomerular filtration rate and cardiovascular risk: prognostic and therapeutic implications].
Ratto E; Leoncini G; Viazzi F; Pontremoli R
G Ital Nefrol; 2008; 25(1):21-31. PubMed ID: 18264915
[TBL] [Abstract][Full Text] [Related]
8. Slowing progression along the renal disease continuum.
Kopyt NP
J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
[TBL] [Abstract][Full Text] [Related]
9. [Control of arterial pressure in diabetic nephropathy].
Luño J; García de Vinuesa S
Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
[No Abstract] [Full Text] [Related]
10. [Risk factors in the epidemiology of glaucoma. II].
Gimeno Ortiz A; Jiménez Romano R
Rev Sanid Hig Publica (Madr); 1988; 62(9-12):1741-8. PubMed ID: 3274036
[No Abstract] [Full Text] [Related]
11. The prevalence of cardiovascular disease risk factors in patients from Croatian Zagorje County treated at Department of Medicine, Zabok General Hospital from 2000 to 2006.
Pesek K; Pesek T; Rados M; Buković D; Fures R; Cuk V
Coll Antropol; 2007 Sep; 31(3):709-15. PubMed ID: 18041378
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure and diabetes: vicious twins.
Chokshi NP; Grossman E; Messerli FH
Heart; 2013 Apr; 99(8):577-85. PubMed ID: 23434624
[No Abstract] [Full Text] [Related]
13. Advances in the treatment of diabetic renal disease: focus on losartan.
Rayner B
Curr Med Res Opin; 2004 Mar; 20(3):333-40. PubMed ID: 15025842
[TBL] [Abstract][Full Text] [Related]
14. Kidney disease in diabetology: lessons from 2008.
Schernthaner G
Nephrol Dial Transplant; 2009 Feb; 24(2):396-9. PubMed ID: 19144896
[No Abstract] [Full Text] [Related]
15. Epidemiology and control of hypertension and diabetes in Costa Rica.
Cerdas M
Ren Fail; 2006; 28(8):693-6. PubMed ID: 17162428
[TBL] [Abstract][Full Text] [Related]
16. [Hypertension therapy for type 2 diabetics].
Bönner G
MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
[No Abstract] [Full Text] [Related]
17. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the Diabetes, Heart and Health Survey.
Metcalf PA; Scragg RR; Schaaf D; Dyall L; Black PN; Jackson RT
N Z Med J; 2008 Feb; 121(1269):45-56. PubMed ID: 18278081
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
Ravera M; Paoletti E
Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
[TBL] [Abstract][Full Text] [Related]
19. [Nephrology and hypertension].
Mogensen CE
Journ Annu Diabetol Hotel Dieu; 2003; ():261-77. PubMed ID: 12868315
[No Abstract] [Full Text] [Related]
20. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
